You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (19)

Journals (0)

1-10 of 19 results for Rituximab (131)

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Lack of tumor uptake of 131-I labeled rituximab in a patient with a CD20 positive lymphoma lesion

Retricted access

Research article

First published 2012-12

Lack of tumor uptake of 131-I labeled rituximab in a patient with a CD20 positive lymphoma lesion

L Tran, ADR Huitema, WV Vogel [...]

Journal of Oncology Pharmacy Practice

Select article: The pharmacokinetics of 131 I-rituximab in a patient with CD20 positive Non-Hodgkin Lymphoma: Evaluation of the effect of radioiodination on the biological properties of rituximab

Retricted access

Research article

First published 2011-2

The pharmacokinetics of 131 I-rituximab in a patient with CD20 positive Non-Hodgkin Lymphoma: Evaluation of the effect of radioiodination on the biological properties of rituximab

L. Tran, J.W. Baars, J.P. de Boer [...]

Human Antibodies

Select article: A Simple and Safe Method for 131 I Radiolabeling of Rituximab for Myeloablative High-Dose Radioimmunotherapy

Retricted access

Research article

First published 2009-02

A Simple and Safe Method for 131 I Radiolabeling of Rituximab for Myeloablative High-Dose Radioimmunotherapy

Ly Tran, Joke W. Baars, Harry J. Maessen [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Personalized Dosimetry of 131 I-Rituximab Radioimmunotherapy of Non-Hodgkin Lymphoma Defined by Pharmacokinetics in Bone Marrow and Blood

Retricted access

Research article

First published 2014-02

Personalized Dosimetry of 131 I-Rituximab Radioimmunotherapy of Non-Hodgkin Lymphoma Defined by Pharmacokinetics in Bone Marrow and Blood

Jan A. Boucek, J. Harvey Turner

Cancer Biotherapy and Radiopharmaceuticals

Select article: A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

Open access

Research article

First published 2023

A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma

Yoon Jung Jang, Sang Moo Lim, Inki Lee [...]

Clinical Medicine Insights: Oncology

Select article: 131 I-Anti CD20 Radioimmunotherapy of Relapsed or Refractory Non-Hodgkins Lymphoma: A Phase II Clinical Trial of a Nonmyeloablative Dose Regimen of Chimeric Rituximab Radiolabeled in a Hospital

Retricted access

Research article

First published 2003-08

131 I-Anti CD20 Radioimmunotherapy of Relapsed or Refractory Non-Hodgkins Lymphoma: A Phase II Clinical Trial of a Nonmyeloablative Dose Regimen of Chimeric Rituximab Radiolabeled in a Hospital

J. Harvey Turner, Andrew A. Martindale, Jan Boucek [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Retricted access

Research article

First published 2012-11

Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Paul C. Kruger, Julian P. Cooney, J. Harvey Turner

Cancer Biotherapy and Radiopharmaceuticals

Select article: Radioimmunotherapy with 131 I-Rituximab: What We Know and What We Don't Know

Retricted access

Editorial

First published 2003-08

Radioimmunotherapy with 131 I-Rituximab: What We Know and What We Don't Know

Malik E. Juweid

Cancer Biotherapy and Radiopharmaceuticals

Select article: Improved In Vivo Stability of Radioiodinated Rituximab Using an Iodination Linker for Radioimmunotherapy

Retricted access

Research article

First published 2016-10

Improved In Vivo Stability of Radioiodinated Rituximab Using an Iodination Linker for Radioimmunotherapy

Eun Jung Kim, Byoung Soo Kim, Dan Bee Choi [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Safety and Efficacy of I(131) Tositumomab in the Treatment of non-Hodgkin's Lymphoma

Open access

Review article

First published 2009

Safety and Efficacy of I(131) Tositumomab in the Treatment of non-Hodgkin's Lymphoma

Tim Illidge, Andrei Ivanov, Yong Du

Clinical Medicine Insights: Therapeutics

1
2
10 / page

Article type

Publication date

Subjects

Access